HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Vitreous Biopsy

A vitreous biopsy is a medical procedure involving the extraction and analysis of vitreous humor, the gel-like substance that fills the space between the lens and retina in the eye. This diagnostic technique is primarily employed to investigate various ocular conditions and systemic diseases that may manifest in the eye. During a vitreous biopsy, a small amount of vitreous humor is aspirated from the eye using a fine needle. The collected sample is then subjected to laboratory analysis to identify any abnormalities, such as infections, inflammation, or the presence of malignant cells. This procedure is often considered when traditional diagnostic methods, such as imaging studies or blood tests, fail to provide conclusive results. Vitreous biopsy can aid in the diagnosis and management of conditions such as intraocular infections, uveitis, and intraocular lymphoma. Despite its diagnostic utility, vitreous biopsy is not without risks. Potential complications include infection, bleeding, and damage to surrounding structures. Therefore, the decision to perform a vitreous biopsy is carefully weighed against the potential benefits, and it is typically reserved for cases where the information obtained is crucial for guiding treatment decisions. In conclusion, vitreous biopsy is a specialized procedure used in ophthalmology to gather diagnostic information about various eye conditions. It plays a significant role in elucidating complex cases and guiding appropriate therapeutic interventions when other diagnostic modalities prove inconclusive.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp